Effects of prolonged exposure to pancreatic glucagon on the function, antigenicity and survival of isolated human islets

Diabetes/Metabolism Research and Reviews

Volumn 16, Issue 4, 2000, Pages 281-286

  Del Guerra, S ^a   Lupi, R ^a   Dotta, F ^b   Marselli, L ^a   Lencioni, C ^a   Santangelo, C ^b   Realacci, M ^b   Carmellini, M ^a   Mosca, F ^a   Navalesi, R ^b   Marchetti, P ^b,c  

^a UNIVERSITY OF PISA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c CISANELLO HOSPITAL   (Italy)

Author keywords

Bcl 2; Chemotaxis; Cytokines; Glucagon; Human islets; Insulin release

Indexed keywords

GAMMA INTERFERON; GLUCAGON; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 2; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2;

ADULT; ANTIGENICITY; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; INSULIN RELEASE; LYMPHOCYTE; MACROPHAGE; MALE; MONOCYTE; NICK END LABELING; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 0033852763     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/1520-7560(2000)9999:9999<::AID-DMRR124>3.0.CO;2-Q     Document Type: Article

References (34)

1. Cook DL, Taborsky GJ. Beta cell function and insulin secretion. In Ellenberg & Rifkin's Diabetes Mellitus, Porte D Jr, Sherwin RS (eds). Appleton & Lange: Stamford, Connecticut, 1997; 49-74.
2. Malaisse WJ. Insulin biosynthesis and secretion in vitro. In International Textbook of Diabetes Mellitus, Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds). John Wiley & Sons: Chichester, 1996; 261-284.
3. Robertson RP, Olson LK, Zhang HJ. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 1994; 43: 1085-1089.
4. Eizirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the B-cell function. J Clin Invest 1992; 90: 1263-1268.
5. Davalli AM, Ricordi C, Socci C, et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additonal culture in a normal glucose medium. J Clin Endocrinol Metab 1991; 72: 202-208.
6. Bjork E, Kampe O, Karlsson FA, et al. Glucose regulation of the autoantigen GAD65 in human pancreatic islets. J Clin Endocrinol Metab 1992; 75: 1574-1576.
7. Ekblond A, Schou M, Buschard K. Mononuclear cytotoxicity and proliferation towards glucose stimulated rodent pancreatic islet cells. Autoimmunity 1997; 25: 97-108.
8. Lefebvre PJ. Glucagon and its family revisited. Diabetes Care 1995; 18: 715-730.
9. Moens K, Flamez D, Van Schravendijik C, Ling Z, Pipeleers D, Schuit F. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. Diabetes 1998; 47: 66-72.
10. Bertuzzi F, Berra C, Socci C, Davalli AM, Pozza G, Pontiroli AE. Insulin and glucagon release of human islets in vitro: effects of chronic exposure to glucagon. J Endocrinol 1997; 152: 239-243.
11. Unger RH, Orci L. Glucagon and the alpha cell. Physiology and pathophysiology. N Engl J Med 1981; 304: 1518-1524.
12. Muller WA, Faloona GR, Unger RH. The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest 1971; 50: 1992-1999.
13. Park CR, Exton JH. Glucagon and the metabolism of glucose. In Glucagon: Molecular Physiology, Clinical and Therapeutic Implications, Lefebvre PJ, Unger RH (eds). Pergamon Press: Oxford, 1972; 77-108.
14. Polak JM, Bloom SR. Glucagon-producing tumors and the glucagonoma syndrome. In Endocrine Pathology of the Gut and Pancreas, Dayal Y (ed.). CRC Press: Boca Raton, 1991; 227-240.
15. Marchetti P, Dotta F, Ling Z, et al. The function of pancreatic islets isolated from Type 1 diabetic patients. Diabetes Care 2000; 23: 701-703.
16. Pupilli C, Giannini S, Marchetti P, et al. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes 1999; 48: 2309-2315.
17. Eisentraut AM, Whissen N, Unger R. Incubation damage in the radioimmunoassay for human plasma glucagon and its prevention with Trasylol. Am J Med Sci 1968; 33: 137-142.
18. Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21: 77-89.
19. Kessler L, Jesser C, Lombard Y, et al. Cytotoxicity of peritoneal murine macrophages against encapsulated pancreatic rat islets: in vivo and in vitro studies. J Leukoc Biol 1996; 60: 729-736.
20. Marselli L, Marchetti P, Tellini C, et al. Lymphokine release from human lymphomononuclear cells after co-culture with isolated pancreatic islets: effects of islets species, long-term culture, and monocyte-macrophage cell removal. Cytokine 2000; 12: 503-505.
21. Rodbell M. The actions of glucagon at its receptor: regulation of adenylate cyclase. In Glucagon I: Handbook of Experimental Pharmacology 66/1, Lefebvre PJ (ed.). Springer-Verlag: Heidelberg, 1983; 263-290.
22. Kawai K, Suzuki S, Ohashi S, et al. Comparison of the effects of glucagon-like peptide-1 (1-37) and (7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Endocrinology 1989; 124: 1768-1773.
23. Hosokawa H, Hosokawa YA, Leahy JL. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats. Diabetes 1995; 44: 1328-1333.
24. Purrello F, Rabuazzo AM, Anello M, Patanè G. Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization. Acta Diabetol 1996; 33: 253-256.
25. Paolisso G, Scheen AJ, Albert A, Lefbvre PJ. Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol 1989; 257: E686-E696.
26. Karsten V, Lencioni C, Tritscher S, et al. Chemotactic activity of culture supernatants of free and encapsulated pancreatic rat islets towards peritoneal macrophages. Harm Metab Res 1999; 31: 448-454.
27. Scharp DW, Lacy PE, Santiago JV, et al. Results of our first nine intraportal islet allografts in Type 1, insulin-dependent diabetic patients. Transplantation 1991; 51: 76-85.
28. Warnock GL, Kneteman NM, Ryan E, Seelis REA, Rabinovitch A, Rajotte RV. Normoglycaemia after transplantation of freshly and ctyopreserved pancreatic islets in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 55-58.
29. Ricordi C, Tzakis A, Carroll P, et al. Human islet transplantation in 18 diabetic patients. Transplant Proc 1992; 24: 961-962.
30. Socci C, Falqui L, Davalli AM, et al. Fresh human islet transplantation to replace pancreatic endocrine function in type I diabetic patients. Acta Diabetol 1991; 28: 151-157.
31. Mellgren A, Schnell AH, Petersson B, Andersson A. The renal subcapsular site offers better growth conditions for transplanted mouse pancreatic islet cells than the liver or the spleen. Diabetologia 1986; 29: 670-672.
32. Hiller WFA, Klempnauer J, Luck R, Steiniger B. Progressive deterioration of endocrine function after intraportal but not kidney subcapsular rat islet transplantation. Diabetes 1991; 40: 134-140.
33. Di Mario U, Dotta F. Beta cell autoimmunity 1998. Diabetes Metab Rev 1998; 14: 1-2.
34. Benoist C, Mathis D Cell death mediators in autoimmune diabetes. No shortage of suspects. Cell 1997; 89: 1-3.